These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33377250)

  • 1. Modelling the effect of market forces on the impact of introducing human immunodeficiency virus pre-exposure prophylaxis among female sex workers.
    Quaife M; Terris-Prestholt F; Mukandavire Z; Vickerman P
    Health Econ; 2021 Mar; 30(3):659-679. PubMed ID: 33377250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers.
    Mukandavire Z; Mitchell KM; Vickerman P
    Epidemics; 2016 Mar; 14():62-70. PubMed ID: 26972515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
    Bowring AL; Ampt FH; Schwartz S; Stoové MA; Luchters S; Baral S; Hellard M
    J Int AIDS Soc; 2020 Feb; 23(2):e25442. PubMed ID: 32064765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa.
    Quaife M; Vickerman P; Manian S; Eakle R; Cabrera-Escobar MA; Delany-Moretlwe S; Terris-Prestholt F
    Health Econ; 2018 Oct; 27(10):1550-1566. PubMed ID: 29926508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When are declines in condom use while using PrEP a concern? Modelling insights from a Hillbrow, South Africa case study.
    Grant H; Mukandavire Z; Eakle R; Prudden H; B Gomez G; Rees H; Watts C
    J Int AIDS Soc; 2017 Sep; 20(1):21744. PubMed ID: 28953330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.
    Stone J; Bothma R; Gomez GB; Eakle R; Mukandavire C; Subedar H; Fraser H; Boily MC; Schwartz S; Coetzee J; Otwombe K; Milovanovic M; Baral S; Johnson LF; Venter WDF; Rees H; Vickerman P
    J Int AIDS Soc; 2023 Feb; 26(2):e26063. PubMed ID: 36807874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Whatever is in the ARVs, is Also in the PrEP" Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa.
    Makhakhe NF; Sliep Y; Meyer-Weitz A
    Front Public Health; 2022; 10():691729. PubMed ID: 35784260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual health needs of female sex workers in Côte d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention.
    Becquet V; Nouaman M; Plazy M; Masumbuko JM; Anoma C; Kouame S; Danel C; Eholie SP; Larmarange J;
    BMJ Open; 2020 Jan; 10(1):e028508. PubMed ID: 31919122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors motivating female sex workers to initiate pre- exposure prophylaxis for HIV prevention in Zimbabwe.
    Nhamo D; Duma SE; Ojewole EB; Chibanda D; Cowan FM
    PLoS One; 2022; 17(7):e0264470. PubMed ID: 35797351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Intention to Use HIV Pre-exposure Prophylaxis and Condom Use Among a Sample of Cisgender Female Sex Workers Working Mostly Outdoors in Madrid, Spain.
    Vazquez Guillamet LJ; Valencia J; Ryan P; Cuevas-Tascón G; Del-Olmo-Morales MA; Cobo I; Lazarus JV; Chevance G
    Arch Sex Behav; 2024 Jul; 53(7):2817-2831. PubMed ID: 38858230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Condom failure and pre-exposure prophylaxis use experience among female sex workers in Ethiopia: a qualitative study.
    Amogne MD; Sanders EJ; Belihu WB; Sundewall J; Agardh A
    BMC Public Health; 2022 May; 22(1):1079. PubMed ID: 35641959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Pre-Exposure Prophylaxis Adherence among Female Sex Workers.
    Ghayda RA; Hong SH; Yang JW; Jeong GH; Lee KH; Kronbichler A; Solmi M; Stubbs B; Koyanagi A; Jacob L; Oh H; Kim JY; Shin JI; Smith L
    Yonsei Med J; 2020 May; 61(5):349-358. PubMed ID: 32390358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study.
    Mitchell KM; Prudden HJ; Washington R; Isac S; Rajaram SP; Foss AM; Terris-Prestholt F; Boily MC; Vickerman P
    J Int AIDS Soc; 2016; 19(1):20942. PubMed ID: 27609782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to oral HIV pre-exposure prophylaxis among female sex workers in Kampala, Uganda.
    Nalukwago GK; Isunju JB; Muwonge T; Katairo T; Bunani N; Semitala F; Kyambadde P; Matovu F
    Afr Health Sci; 2021 Sep; 21(3):1048-1058. PubMed ID: 35222566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding issues around use of oral pre exposure prophylaxis among female sex workers in India.
    Sahay S; Verma A; Shewale S; Bangar S; Bijeshkumar A; Angolkar M; Subramanian T; Chandhiok N
    BMC Infect Dis; 2021 Sep; 21(1):930. PubMed ID: 34496781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promise and pitfalls of pre-exposure prophylaxis for female sex workers.
    Cowan FM; Delany-Moretlwe S
    Curr Opin HIV AIDS; 2016 Jan; 11(1):27-34. PubMed ID: 26633639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.